The future of skin cancer treatment is now. Stay ahead of the curve with our library of informational blogs.
Melanoma and non-melanoma are two primary categories of skin cancer. Each presents different symptoms and treatment options. Within the non-melanoma skin cancer – sometimes referred to as NMSC – category, the two most common types…
Patients and physicians both are talking about revolutionary keloid treatment offered by the SRT-100™. Hear what they have to say. :
…– Q2 revenues increased 49% year-over-year to $3.6 million – Worldwide installed base increased to 247 units -Successfully completed IPO on June 2nd; cash of $15.8 million, with no debt, at June 30, 2016 BOCA…
By Mike Masterson Posted: August 2, 2016 at 5:45 a.m. Editor’s note: The original version of the column was published March 9, 2014. There the thing still was, frowning from the mirror. That crusty red…
BOCA RATON, Fla., Aug. 2, 2016 — Sensus Healthcare, Inc. (NASDAQ: SRTS; SRTSW), a medical device company specializing in the treatment of non-melanoma skin cancers and other skin conditions, such as keloids, with superficial radiation…
